Lv21
152 积分 2021-05-08 加入
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells
3小时前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1个月前
已完结
The U.S. Food and Drug Administration’s Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Conditions
1个月前
已完结
Prediction of First-in-Human Dose of Chimeric Antigen Receptor-T (CAR-T) Cells from Mice
1个月前
已完结
嵌合抗原受体T细胞治疗复发难治性自身免疫病专家共识（2025版）
2个月前
已完结
THE GADEKILL GMP-CELL PRODUCT AS NOVEL IMMUNOTHERAPEUTIC TOOL FOR NEUROBLASTOMA PATIENTS RECEIVING A HAPLOIDENTICAL HSCT
3个月前
已关闭
CAR-T Rapid Manufacturing: Implications on Product and Analytical Testing
3个月前
已完结
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer
3个月前
已完结
Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
3个月前
已完结
皖公网安备34019202002308
